Cetrorelix 0.25mg Injection

Cetrorelix 0.25 mg Injection: Crucial Premature Ovulation Prevention in IVF

Cetrorelix 0.25 mg Injection is a highly specialized injectable medication formulated with cetrorelix acetate. As a generic counterpart to the brand-name drug Cetrotide, it offers identical biological efficacy, safety profiles, and clinical reliability. It serves as a cornerstone therapy in controlled ovarian hyperstimulation (COH) protocols for women undergoing fertility treatments.

Clinical Mechanism of Action

• GnRH Receptor Antagonism: Cetrorelix works by binding directly and competitively to membrane receptors on pituitary cells.

• LH Surge Suppression: By blocking natural GnRH signals, it induces immediate suppression of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) secretion. This prevents an early "LH surge," which would otherwise cause the ovaries to release eggs before they are fully mature and ready for retrieval.

Therapeutic Indications: What Conditions Does Cetrorelix Treat?

COMPARATIVE ANALYSIS: IVF DOWN-REGULATION OPTIONS

• Immediate LH Suppression: Unlike GnRH agonists, cetrorelix provides instant hormone suppression without an initial flare effect, reducing overall injection days.

• Optimized Egg Quality: Allows fertility specialists to precisely schedule the final human chorionic gonadotropin (hCG) or trigger shot for maximum egg maturity.

• Bioequivalent Alternative: Provides a cost-effective choice for self-funded or out-of-pocket fertility patients compared to brand-name alternatives.

• High-Precision Subcutaneous Delivery: Typically packaged as a convenient single-dose vial with a solvent syringe for straightforward, fine-needle administration.

• Strict Fertility Protocol: Must be administered exactly on the specific cycle days instructed by your reproductive endocrinologist (commonly starting on stimulation day 5 or 6, or when follicles reach 12–14 mm).

• Administration Site: Delivered via subcutaneous (SC) injection into the lower abdominal wall. Rotate injection sites daily to minimize localized sensitivity.

• Storage Protocols: Store between 2°C and 8°C (Refrigerate. Do not freeze). Keep the container in the outer carton to protect the medication from direct light exposure.

• Injection Site Reactions: Mild, temporary redness, bruising, itching, or swelling at the subcutaneous puncture site may occur.

• Ovarian Hyperstimulation Syndrome (OHSS): While cetrorelix helps manage cycles, the underlying gonadotropin stimulation carries risks of OHSS. Report severe pelvic pain, bloating, or sudden weight gain immediately.

• Contraindications: Do not use if you are already pregnant, breastfeeding, or have a history of severe renal impairment or hypersensitivity to cetrorelix acetate.